نتایج جستجو برای: opg

تعداد نتایج: 2111  

Journal: :Clinical science 2006
Ingunn Holen Claire M Shipman

OPG (osteoprotegerin), a secreted member of the TNF (tumour necrosis factor) receptor superfamily, has a variety of biological functions which include the regulation of bone turnover. OPG is a potent inhibitor of osteoclastic bone resorption and has been investigated as a potential therapeutic for the treatment of both osteoporosis and tumour-induced bone disease. Indeed, in murine models of ca...

2015
Shyan-Yuan Kao Konstantina M. Stankovic

Osteoprotegerin (OPG) is a key regulator of bone remodeling. Mutations in OPG are involved in a variety of human diseases. We have shown that cochlear spiral ganglion cells secrete OPG at high levels and lack of OPG causes sensorineural hearing loss in addition to the previously described conductive hearing loss. In order to study the regulation of OPG expression, we conducted a database search...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2006
Brian J Bennett Marta Scatena Elizabeth A Kirk Marcello Rattazzi Rebecca M Varon Michelle Averill Stephen M Schwartz Cecilia M Giachelli Michael E Rosenfeld

OBJECTIVE Osteoprotegerin (OPG), a member of the tumor necrosis factor (TNF) superfamily of proteins, plays an important role in bone remodeling and is expressed in both mouse and human atherosclerotic lesions. The current study was designed to assess whether OPG plays a role in the progression and calcification of advanced atherosclerotic lesions in apoE(-/-) mice. METHODS AND RESULTS Athero...

Journal: :Clinical biochemistry 2014
Carmen Pérez de Ciriza María Moreno Patricia Restituto Gorka Bastarrika Isabel Simón Inmaculada Colina Nerea Varo

CONTEXT The relationship between osteoprotegerin (OPG) a glycoprotein related to bone metabolism and the metabolic syndrome (MS) has not been established. OBJECTIVE The aim of this study is to evaluate OPG concentration in patients with MS and its association with subclinical atherosclerosis and coronary arterial calcification (CAC). MATERIALS/METHODS The study included 238 asymptomatic pat...

2012
Marc D. Ryser Yiding Qu Svetlana V. Komarova

Bone is a common site for cancer metastasis. To create space for their growth, cancer cells stimulate bone resorbing osteoclasts. Cytokine RANKL is a key osteoclast activator, while osteoprotegerin (OPG) is a RANKL decoy receptor and an inhibitor of osteoclastogenesis. Consistently, systemic application of OPG decreases metastatic tumor burden in bone. However, OPG produced locally by cancer ce...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2012
Dave Koole Rob Hurks Arjan Schoneveld Aryan Vink Jonathan Golledge Corey S Moran Dominique P de Kleijn Joost A van Herwaarden Jean-Paul de Vries Jon D Laman Ruth Huizinga Gerard Pasterkamp Frans L Moll

OBJECTIVE Serum osteoprotegerin (OPG) concentrations have previously been associated with growth of abdominal aortic aneurysms (AAAs). In vitro experiments showed that OPG promotes matrix metalloprotease (MMP) release from monocytes and vascular smooth muscle cells. We hypothesized that OPG expression is increased in human AAAs and is associated with proteolysis. METHODS AND RESULTS AAA biops...

2015
Baoli Wang Hongting Jin Bing Shu Ranim R. Mira Di Chen

Bone marrow stromal cells/osteoblasts were originally thought to be the major player in regulating osteoclast differentiation through expressing RANKL/OPG cytokines. Recent studies have established that chondrocytes also express RANKL/OPG and support osteoclast formation. Till now, the in vivo function of chondrocyte-produced OPG in osteoclast formation and postnatal bone growth has not been di...

2012
Richard M Elias John T Wald David F Kallmes

BACKGROUND The purpose of this study was to assess the accuracy of oculopneumoplethysmography (OPG) for the diagnosis of carotid artery stenosis both alone and in conjunction with carotid magnetic resonance angiography (MRA). METHODS This retrospective study reviewed patients who had undergone both OPG and digital subtraction angiography (DSA, 90 patients, 174 vessels) within two weeks to det...

Journal: :Human molecular genetics 2014
Johnny S H Kwan Yi-Hsiang Hsu Ching-Lung Cheung Josée Dupuis Aude Saint-Pierre Joel Eriksson Samuel K Handelman Aaron Aragaki David Karasik Peter P Pramstaller Charles Kooperberg Andrea Z Lacroix Martin G Larson Kam-Shing Lau Mattias Lorentzon Irene Pichler Pak C Sham Daniel Taliun Liesbeth Vandenput Douglas P Kiel Andrew A Hicks Rebecca D Jackson Claes Ohlsson Emelia J Benjamin Annie W C Kung

Osteoprotegerin (OPG) is involved in bone homeostasis and tumor cell survival. Circulating OPG levels are also important biomarkers of various clinical traits, such as cancers and atherosclerosis. OPG levels were measured in serum or in plasma. In a meta-analysis of genome-wide association studies in up to 10 336 individuals from European and Asian origin, we discovered that variants >100 kb up...

Journal: :Cell 1997
W. S Simonet D. L Lacey C. R Dunstan M Kelley M.-S Chang R Lüthy H. Q Nguyen S Wooden L Bennett T Boone G Shimamoto M DeRose R Elliott A Colombero H.-L Tan G Trail J Sullivan E Davy N Bucay L Renshaw-Gegg T. M Hughes D Hill W Pattison P Campbell S Sander G Van J Tarpley P Derby R Lee W. J Boyle

A novel secreted glycoprotein that regulates bone resorption has been identified. The protein, termed Osteoprotegerin (OPG), is a novel member of the TNF receptor superfamily. In vivo, hepatic expression of OPG in transgenic mice results in a profound yet nonlethal osteopetrosis, coincident with a decrease in later stages of osteoclast differentiation. These same effects are observed upon admin...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید